HSC activation. Therefore, the use of hBM-MSCs-Ex presents a new and promising therapeutic strategy for hepatic disease in the clinical setting. Notes Xiaoli Rong and Junzhi Liu are co-first author
TBIL Total bilirubin TP Total protein α-SMA Alpha-smooth muscle actin γ-GT Gamma glutamyl transpeptidase Xiaoli Rong and Junzhi Liu are co-first author and contributed equally to this work Electronic
53706, USA Received 28 June 2014; Revised 3 September 2014; Accepted 4 September 2014 Academic Editor: Eduardo García-Ortega Copyright © 2015 Junzhi Liu et al. This is an open access article
53706, USA Received 28 June 2014; Revised 3 September 2014; Accepted 4 September 2014 Academic Editor: Eduardo García-Ortega Copyright © 2015 Junzhi Liu et al. This is an open access article
53706, USA Received 28 June 2014; Revised 3 September 2014; Accepted 4 September 2014 Academic Editor: Eduardo García-Ortega Copyright © 2015 Junzhi Liu et al. This is an open access article
53706, USA Received 28 June 2014; Revised 3 September 2014; Accepted 4 September 2014 Academic Editor: Eduardo García-Ortega Copyright © 2015 Junzhi Liu et al. This is an open access article
